
    
      This study is dose block-randomized, double-blind, placebo controlled, multiple-dosing, dose
      escalation clinical trial to investigate the safety, tolerability and pharmacokinetic
      characteristics of DWP 10292 after oral administration in healthy male subjects.
    
  